UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 1-5677
Wang Laboratories, Inc.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
209 Concord Road, Billerica, MA 01821-4130, Telephone: (978) 625-5000
- --------------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
- --------------------------------------------------------------------------------
Common Stock, par value $0.01 per share (including associated rights).
CUSIP Number: 93369N109
Common Stock Purchase Warrants
CUSIP Number: 93369N117
Depositary Shares1
CUSIP Number: 93369N604
93369N208
- --------------------------------------------------------------------------------
(Title of each class of securities covered by this Form)
None
- --------------------------------------------------------------------------------
(Titles of all other classes of securities for which a duty to file reports
under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) |X| Rule 12h-3(b)(1)(i) |X|
Rule 12g-4(a)(1)(ii) |_| Rule 12h-3(b)(1)(ii) |_|
- ------------------
1 Each Depositary Share represents a 1/20th interest in a share of 6 1/2%
Series B Cumulative Convertible Preferred Stock, par value $0.01 per share.
<PAGE>
Rule 12g-4(a)(2)(i) |_| Rule 12h-3(b)(2)(i) |_|
Rule 12h-3(b)(2)(ii) |_| Rule 12g-4(a)(2)(ii) |_|
Rule 15d-6 |_|
Approximate number of holders of record as of the certification or notice date:
CUSIP Numbers: 93369N109 (Common Stock) 0 (Zero)
93369N117 (Common Stock Purchase Warrants) 0 (Zero)
93369N604 (Depositary Shares) 0 (Zero)
93369N208 (Depositary Shares) 0 (Zero)
<PAGE>
Pursuant to the requirements of the Securities and Exchange Act of 1934
Wang Glogbal Corporation* has caused this certification/notice to be signed on
its behalf by the undersigned duly authorized person.
Date: June 24, 1999 By:/S/ PAUL F. BRAUNEIS
-----------------------------------------------
Name: Paul F. Brauneis
Title: Vice President and Corporate Controller
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the
General Rules and Regulations under the Securities Exchange Act of 1934. The
registrant shall file with the Commission three copies of Form 15, one of which
shall be manually signed. It may be signed by an officer of the registrant, by
counsel or by any other duly authorized person. The name and title of the person
signing the form shall be typed or printed under the signature.
- ---------------
* The surviving corporation of the merger of Getronics Acquisition, Inc. with
and into Wang Laboratories, Inc. pursuant to the certificate of ownership
and merger dated June 18, 1999 and filed with the Secretary of State of
Delaware on June 22, 1999.
